KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,190,212 | +7.0% | 3,238,859 | 0.0% | 2.07% | +19.0% |
Q2 2023 | $29,149,731 | +14.5% | 3,238,859 | 0.0% | 1.74% | -5.5% |
Q1 2023 | $25,457,432 | +16.3% | 3,238,859 | 0.0% | 1.84% | +35.4% |
Q4 2022 | $21,894,687 | -4.0% | 3,238,859 | +106.0% | 1.36% | -22.5% |
Q3 2022 | $22,813,000 | +47.5% | 1,572,192 | 0.0% | 1.76% | +20.3% |
Q2 2022 | $15,470,000 | -33.2% | 1,572,192 | 0.0% | 1.46% | -26.1% |
Q1 2022 | $23,174,000 | – | 1,572,192 | – | 1.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |